Simplify Logo

Full-Time

Senior Statistical Programmer

Temporary

Posted on 6/27/2024

Vir Biotechnology

Vir Biotechnology

501-1,000 employees

Develops treatments for infectious diseases

Data & Analytics
Hardware
Biotechnology
Healthcare

Expert

San Francisco, CA, USA

Category
Data Analysis
Data & Analytics
Required Skills
Word/Pages/Docs
PowerPoint/Keynote/Slides
Requirements
  • Bachelor’s degree or higher in Statistics, Mathematics, Computer Science, or related field
  • Minimum of ten (10) years’ SAS programming experience in pharmaceutical/biotech industry with CDISC standards
  • Experience in creating source and validation programs using SAS software for SDTM datasets, ADaM datasets, and TFLs
  • Expertise in system-level macro programs
  • Proficiency in SAS/GTL programming
  • Proficient in Microsoft Word, Excel, and PowerPoint
Responsibilities
  • Perform data manipulation, analysis, and reporting of clinical trial data
  • Develop and maintain department/system-level macros
  • Create/review SDTM and ADaM specifications
  • Create/validate SDTM data sets
  • Create/validate analysis data sets
  • Create/validate patient profiles
  • Program and generate tables, figures, and listings (TFLs)
  • Validate and document SAS programs and output
  • Fulfill ad-hoc analysis requests
  • Provide other services as identified by Vir Biotechnology

Vir Biotechnology is at the forefront of combating infectious diseases, leveraging advanced technologies such as a proprietary monoclonal antibody platform along with machine learning and artificial intelligence. This focus not only prioritizes public health but also fosters a culture of continuous innovation and commitment to scientific excellence. Working here means contributing to pivotal developments that address some of the most pressing global health challenges today, such as influenza, HIV, and COVID-19, in an environment that values cutting-edge research and a collaborative spirit.

Company Stage

Grant

Total Funding

$908.6M

Headquarters

San Francisco, California

Founded

2016

Growth & Insights
Headcount

6 month growth

-2%

1 year growth

1%

2 year growth

10%
Simplify Jobs

Simplify's Take

What believers are saying

  • Recent bullish quarterly reports and increased analyst estimates suggest strong financial performance.
  • Significant investments, such as the $214,000 from Diversified Trust Co, indicate confidence in Vir's future prospects.
  • Presentations at high-profile conferences like J.P. Morgan's Annual Healthcare Conference and AASLD's The Liver Meeting® enhance Vir's visibility and credibility in the biotech community.

What critics are saying

  • Recent layoffs and facility shutdowns indicate potential financial instability and operational challenges.
  • The resignation of key executives, including the CFO and Chief Medical Officer, could lead to strategic and leadership uncertainties.

What makes Vir Biotechnology unique

  • Vir Biotechnology's focus on leveraging immunology expertise to engineer human antibodies into powerful medicines sets it apart from competitors.
  • Their rapid growth, as evidenced by being ranked the fastest-growing company in North America on the 2023 Deloitte Technology Fast 500, highlights their market impact.
  • Vir's ongoing Phase 2 trials for chronic hepatitis delta and B demonstrate their commitment to addressing unmet medical needs with innovative therapies.

Benefits

Comprehensive healthcare coverage

Employer matched 401(k)

Employee stock purchase plan

Childcare assistance

Tuition reimbursement

INACTIVE